Technology

ASML Holding (NASDAQ: ASML) Stock Analyst Ratings

/ / Technology /

ASML Holding (NASDAQ: ASML) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/25/2024 17.44% Raymond James $850 → $1000 Maintains Strong Buy 01/19/2024 -0.18% Raymond James $725 → $850 Maintains Strong Buy 11/30/2023 3.11% JP Morgan $726 → $878 Maintains Overweight 10/19/2023 -14.74% JP Morgan $732 → $726 Maintains Overweight 10/12/2023 -4.87% Susquehanna $850 → $810 Maintains Positive 10/11/2023 -14.03% JP Morgan $772 → $732 Maintains Overweight 07/28/2023 — Bernstein Downgrades Outperform → Market Perform 07/20/2023 -6.05% Wells Fargo $775 → $800 Maintains Overweight 06/16/2023 — New Street Research Downgrades Buy → Neutral 01/26/2023 -8.98% Argus Research $590 → $775 Maintains Buy 01/26/2023 -11.69% JP Morgan $710 → $752 Maintains Overweight 11/14/2022 — Susquehanna Upgrades Neutral → Positive 11/14/2022 -21.9% Wells Fargo $510 → $665 Maintains Overweight 11/08/2022 — Morgan Stanley Initiates Coverage On → Overweight 10/21/2022 — New Street Research Upgrades […]

ASML Holding (NASDAQ: ASML) Stock Analyst Ratings Read Post »

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings

/ / Technology /

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/25/2024 13% Piper Sandler → $455 Reiterates Overweight → Overweight 01/23/2024 49.01% Truist Securities → $600 Reiterates Buy → Buy 01/18/2024 16.98% Exane BNP Paribas → $471 Upgrades Neutral → Outperform 01/12/2024 13% Piper Sandler → $455 Reiterates Overweight → Overweight 01/09/2024 4.31% BMO Capital $400 → $420 Maintains Outperform 01/02/2024 13% Piper Sandler $425 → $455 Maintains Overweight 12/28/2023 11.76% Wedbush $425 → $450 Maintains Outperform 12/15/2023 11.76% Mizuho $420 → $450 Maintains Buy 12/13/2023 49.01% Truist Securities → $600 Initiates Coverage On → Buy 12/05/2023 6.79% Argus Research $390 → $430 Maintains Buy 12/05/2023 15.73% China Renaissance → $466 Initiates Coverage On → Buy 11/29/2023 17.97% Tigress Financial $433 → $475 Maintains Buy 11/24/2023 4.31% Mizuho $420 → $420 Reiterates Buy → Buy 11/24/2023 -3.14% RBC Capital $390 → $390

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings Read Post »

ServiceNow (NYSE:NOW) Stock Analyst Ratings

/ / Technology /

ServiceNow (NYSE:NOW) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/25/2024 16.81% Needham → $900 Reiterates Buy → Buy 01/23/2024 12.92% Barclays $765 → $870 Maintains Overweight 01/22/2024 7.08% JMP Securities $665 → $825 Maintains Market Outperform 01/22/2024 16.81% Needham $660 → $900 Maintains Buy 01/18/2024 3.83% Oppenheimer $750 → $800 Maintains Outperform 01/16/2024 -9.15% Truist Securities $575 → $700 Maintains Hold 01/11/2024 -3.96% Stifel $650 → $740 Maintains Buy 12/06/2023 -0.06% Argus Research $675 → $770 Maintains Buy 11/30/2023 -5.9% Wells Fargo $675 → $725 Maintains Overweight 11/09/2023 -11.74% RBC Capital $665 → $680 Maintains Outperform 10/26/2023 -15.64% Stifel $640 → $650 Maintains Buy 10/26/2023 -19.53% Piper Sandler $600 → $620 Maintains Overweight 10/26/2023 -18.23% BMO Capital $615 → $630 Maintains Outperform 10/26/2023 -12.39% Wells Fargo $650 → $675 Maintains Overweight 10/26/2023 -15.9% Morgan Stanley $630 → $648 Maintains Overweight 10/26/2023

ServiceNow (NYSE:NOW) Stock Analyst Ratings Read Post »

Lam Research (NASDAQ:LRCX) Stock Analyst Ratings

/ / Technology /

Lam Research (NASDAQ:LRCX) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/25/2024 5.51% Needham $800 → $900 Maintains Buy 01/23/2024 -2.7% Cantor Fitzgerald → $830 Initiates Coverage On → Neutral 01/19/2024 -0.35% Raymond James $725 → $850 Maintains Outperform 01/16/2024 -0.35% Stifel $750 → $850 Maintains Buy 01/16/2024 -12.08% Barclays $600 → $750 Maintains Equal-Weight 12/08/2023 -15.59% Morgan Stanley → $720 Downgrades Overweight → Equal-Weight 11/22/2023 -6.21% Redburn Atlantic → $800 Initiates Coverage On → Buy 10/19/2023 -17.94% JP Morgan $720 → $700 Maintains Overweight 10/19/2023 -17.94% B. Riley Securities $690 → $700 Maintains Neutral 10/13/2023 -6.21% Needham → $800 Upgrades Hold → Buy 10/05/2023 -15.01% UBS $750 → $725 Maintains Buy 09/15/2023 -3.28% Wolfe Research → $825 Initiates Coverage On → Outperform 08/28/2023 -12.08% Stifel $725 → $750 Maintains Buy 07/27/2023 -15.59% Morgan Stanley $550 → $720 Maintains Overweight 07/27/2023 -15.59%

Lam Research (NASDAQ:LRCX) Stock Analyst Ratings Read Post »

IBM (NYSE:IBM) Stock Analyst Ratings

/ / Technology /

IBM (NYSE:IBM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/25/2024 -0.01% Stifel $183 → $190 Maintains Buy 01/22/2024 -3.7% Stifel $144 → $183 Maintains Buy 01/19/2024 5.25% Evercore ISI Group $165 → $200 Upgrades In-Line → Outperform 01/05/2024 -5.28% Jefferies → $180 Initiates Coverage On → Hold 01/05/2024 -24.75% Societe Generale → $143 Downgrades Hold → Sell 11/13/2023 -26.33% Wedbush → $140 Reiterates Neutral → Neutral 10/26/2023 -5.8% RBC Capital $188 → $179 Maintains Outperform 10/26/2023 -18.43% BMO Capital $152 → $155 Maintains Market Perform 10/26/2023 -26.33% Wedbush → $140 Reiterates Neutral → Neutral 10/17/2023 -31.59% Morgan Stanley $135 → $130 Maintains Equal-Weight 09/20/2023 -1.07% RBC Capital → $188 Initiates Coverage On → Outperform 07/20/2023 -15.8% B of A Securities $152 → $160 Maintains Buy 07/20/2023 -24.22% Stifel $140 → $144 Maintains Buy 07/20/2023 -28.96% Morgan Stanley $135 → $135 Reiterates

IBM (NYSE:IBM) Stock Analyst Ratings Read Post »

CFRA Maintains Buy Rating On Shares Of International Business Machines (IBM )Corp.

/ / Technology /

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our price target by $19 to $196, utilizing a P/E of 19x our ’24 EPS estimate, near peers and above IBM’s 3-year historical average (~14x) and our previous multiple (17.5x) as IBM continues to execute its growth and cost-cutting initiatives despite a tough macro. We raise our ’24 EPS view by $0.20 to $10.30 and raise our ’25 view by $0.38 to $10.90. IBM prints Q4 sales of $17.4B and EPS of $3.87, both slightly above consensus ($17.3B/$3.78). Quarterly sales grew 4.1% Y/Y, highlighted by strong growth in Consulting (up 5.8%), which also exhibited an impressive quarterly book-to-bill of 1.30 (and 1.15 for the full year). We think IBM’s unique ability to provide consulting along with top-notch proprietary hardware and software solutions (including watsonx for

CFRA Maintains Buy Rating On Shares Of International Business Machines (IBM )Corp. Read Post »

CFRA Maintains Hold Opinion On Shares Of Intel Corp.

/ / Technology /

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our 12-month target to $50 from $39, on P/E of 18.6x our ’25 EPS view, near peers/above historical. We keep our ’24 EPS at $1.94 and boost ’25 to $2.69 from $2.41. Ahead of Q4 results set for after the close, we see EPS of $0.45 at $15.2B in revenue and a 46.5% gross margin. We look for indications that PC vendors still possess healthy inventories after a seasonal strong H2 last year along with improving landscape for ’24 data center server builds. Mobileye is a minor headwind. Commentary on the gross margin trajectory in ’24 will be critical (we see 47%) as well as capital spending plans (seen at $22B; capital intensity of 36%) that likely imply another year of negative FCF (cost cuts

CFRA Maintains Hold Opinion On Shares Of Intel Corp. Read Post »

CFRA Downgrades Shares Of Lam Research Corporation To Hold From Buy

/ / Technology /

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our price target by $36 to $777, 25x our CY 24 EPS view of $31.07, a premium to Lam’s 3-year historical average (~19x) and above our previous multiple (24x) on LRCX’s rising exposure to key technology inflections and increasing confidence that the memory market is entering an upcycle. We raise our FY 24 (Jun.) EPS view to $29.33 from $28.73 and lower FY 25’s to $35.08 from $35.43. Memory grew to 48% of Dec-Q sales (vs. 38% in Sep-Q), driven by growth in DRAM (31% vs. 23%), largely a result of continuing demand for high-bandwidth memory to support AI applications. We see this continuing in CY 24 and expect memory will account for a larger proportion of sales, supported by stable shipments into China. We

CFRA Downgrades Shares Of Lam Research Corporation To Hold From Buy Read Post »

Apple Vision Pro 2024 Sales Poised to Soar Following ‘Very Impressive’ Launch, Wedbush Says

/ / Technology /

Apple (AAPL) is likely to ship and sell nearly 600,000 Vision Pro mixed-reality headsets this year, up from an initially estimated 460,000 units, following a “very impressive” launch, Wedbush Securities said Wednesday. The brokerage’s initial estimates suggest the technology giant sold “close to” 180,000 Vision Pro units over the weekend, Wedbush analysts, including Daniel Ives, said in a note. “While many on the Street are dismissing Vision Pro as noise, we strongly disagree.” “We believe this is just the start for this new form factor, with our industry checks showing the next version of Vision Pro 2 will have much lower price points in the sub $2k area code, as Apple looks to push more aggressively towards its golden installed base,” the analysts said. Wedbush maintained its outperform rating and $250 price target on the Apple stock.

Apple Vision Pro 2024 Sales Poised to Soar Following ‘Very Impressive’ Launch, Wedbush Says Read Post »

Intel Likely to See ‘Modest’ Q4 Outperformance, BofA Says

/ / Technology /

Intel (INTC) is likely to see “modest” outperformance in Q4, but could miss Q1 consensus amid multiple headwinds, BofA Securities said in a Tuesday note. While BofA forecasts Q4 to be in line with or slightly ahead, with projected figures of $15.1 billion in sales and 46.5% gross margin, it expects a miss in Q1, pointing to headwinds such as Mobileye outlook cut, PC seasonality, weak industrial/auto, networking and muted enterprise. “We tweak down Q1 and CY24 sales, but believe the GM trajectory could surprise to the upside as INTC benefits from its cost restructuring actions, leading to higher EPS,” BofA said. The brokerage reiterated its neutral rating on Intel with a price objective of $50.

Intel Likely to See ‘Modest’ Q4 Outperformance, BofA Says Read Post »

Scroll to Top